We created a suite of assets to support the launch of a new molecule. These included; talking heads with the senior team about the work undergone to achieve EC approval, an animation explaining the history of the drug from molecular discovery and a series of interviews with patients across Europe giving heartfelt accounts of what it is like to live with the condition and what new treatment options mean to them.

Back to work...